Exascale Labs and BCAR announce SEC effectiveness of S-4
Exascale Labs Inc. and D. Boral ARC Acquisition I Corp. announced the SEC declared their Form S-4 registration statement effective on June 24, 2026, advancing their proposed business combination. The merger requires BCAR shareholder approval and satisfaction of closing conditions. Upon completion, the company will operate as Exascale Labs Holdings Inc. and trade on Nasdaq under the ticker "XLAB."
*this image is generated using AI for illustrative purposes only.
Exascale Labs Inc. and D. Boral ARC Acquisition I Corp. announced that the registration statement on Form S-4 regarding their proposed business combination was declared effective by the Securities and Exchange Commission as of June 24, 2026. The effectiveness marks a significant step toward finalizing the merger between the AI compute infrastructure provider and the special purpose acquisition company. The transaction remains subject to approval by BCAR’s shareholders and the satisfaction of other customary closing conditions.
The registration statement will be supplemented by a definitive proxy statement/prospectus in connection with an Extraordinary General Meeting of BCAR shareholders. BCAR expects to file the definitive proxy statement/prospectus in the coming days. The business combination is anticipated to close shortly after the extraordinary general meeting once all closing conditions have been satisfied or waived.
"The SEC's declaration of effectiveness of our Form S-4 is a significant milestone in our journey to become a public company," said Dr. Hoansoo Lee, Chief Executive Officer of Exascale. He added that the transaction would position the company to accelerate its long-term growth strategy and broaden its access to capital.
John Darwin, Chief Financial Officer of BCAR, expressed confidence in Exascale, noting the company pairs accelerating demand in a high-growth industry with multi-year, contracted commitments. He stated that BCAR is focused on completing the transaction and welcoming Exascale to the public markets.
Transaction Details
The Business Combination Agreement was entered into as of January 12, 2026, among BCAR, Exascale, and D. Boral ARC Merger Corporation. Upon closing, Pubco is expected to operate as Exascale Labs Holdings Inc. Its shares are expected to trade on Nasdaq under the ticker symbol "XLAB."
| Entity | Role | Expected Outcome |
|---|---|---|
| Exascale Labs Inc. | Target | Become public via merger |
| D. Boral ARC Acquisition I Corp. | SPAC | Merge with Exascale |
| Exascale Labs Holdings Inc. | Post-merger entity | Trade on Nasdaq as "XLAB" |
Company Profiles
D. Boral ARC Acquisition I Corp. is a special purpose acquisition company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Exascale Labs is a next-generation AI infrastructure provider operating an asset-light, software-defined GPU compute platform. Its core business includes GPU-as-a-Service, providing reserved and on-demand access to high-performance GPU compute capacity. Additionally, Exascale has developed modular data center, high-density cooling, HVDC power, and energy storage solutions designed to address deployment bottlenecks in AI infrastructure.
How will Exascale Labs utilize the influx of capital from the merger to scale its GPU-as-a-Service platform?
What are the expected post-merger synergies between Exascale's software-defined platform and BCAR's strategic objectives?
How might the debut of 'XLAB' on Nasdaq influence investor sentiment toward other AI infrastructure SPAC deals?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
